Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Savara Granted Breakthrough Therapy Designation for Molgradex

Tuesday, December 31, 2019

Savara Inc an orphan lung disease company announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for Molgradex an inhaled formulation of recombinant human granulocytemacrophage colonystimulating factor GMC...

Acceleron and Fulcrum Therapeutics Announce Pulmonary Research and Discovery Collaboration Agreement

Tuesday, December 31, 2019

Acceleron Pharma Inc a leading biopharmaceutical company in the discovery and development of TGFbeta superfamily therapeutics to treat serious and rare diseases and Fulcrum Therapeutics Inc a clinicalstage biopharmaceutical company focused on improvi...

Cyclo Therapeutics Signs Master Services Agreement with Worldwide Clinical Trials

Monday, December 30, 2019

Cyclo Therapeutics Inc a clinicalstage biotechnology company that develops cyclodextrinbased products for the treatment of NiemannPick Disease Type C NPC and Alzheimers Disease today announced that it has signed a Master Services Agreement with World...

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

Friday, December 27, 2019

South Korea the CDMO segment of the worlds leading biotech company GenScript announced that it signed a strategic collaboration agreement with Selecxine Inc a Korean biotech company dedicated to novel therapeutics for immunooncology The parties have...

Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.

Friday, December 27, 2019

Astellas Pharma Inc and Xyphos Biosciences Inctoday announced that Astellas has acquired Xyphos With the acquisition Astellas will gain Xyphos novel and proprietary ACCEL Advanced Cellular Control through Engineered Ligands technology platform as wel...

LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma

Tuesday, December 24, 2019

LEO Pharma announced the sale of products to Karo Pharma AB for MEUR The divested portfolio is noncore to LEO Pharmas business and was part of the portfolio acquired from Bayer in July

Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy

Tuesday, December 24, 2019

Roche and Sarepta Therapeutics Inc today announced the signing of a licensing agreement providing Roche exclusive commercial rights to SRP AAVrhMHCKmicrodystrophin Sareptas investigational gene therapy for Duchenne muscular dystrophy DMD outside the...

Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program

Tuesday, December 24, 2019

Theravance Biopharma Ireland Limited a subsidiary of Theravance Biopharma Inc and Pfizer Inc today announced that the companies have entered into a global license agreement for Theravance Biopharmas preclinical program for skintargeted locallyacting...

Sosei Heptares Announces the First Phase I Clinical Start From Its Multi-target Drug Discovery Collaboration With Pfizer

Monday, December 23, 2019

Sosei Group Corporation has been notified by its strategic alliance partner Pfizer that it has dosed the first subject in a clinical trial with a new drug candidate nominated from the multitarget drug discovery collaboration between the two companies...

Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer

Saturday, December 21, 2019

Johnson Johnson announced today the acquisition of TARIS Biomedical LLC TARIS a privatelyowned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including cancer The compa...

Latest Issue
Get instant
access to our latest e-book